SCHEMBL631062

SCHEMBL631062

CC(C)Cc1cccc(N2CC[N]CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.44
AGXT P21549 3/20 0.42
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MBTD1 Q05BQ5 1/20 0.37
TP53BP1 Q12888 1/20 0.37
L3MBTL3 Q96JM7 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GFER P55789 1/20 0.36
ADRA2C P18825 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4576037 0.85 PRMT6 (0.59) PRMT6AGXTMAPTMBTD1TP53BP1
SCHEMBL30228501 0.84 PRMT6 (0.62) PRMT6AGXTMAPTMBTD1TP53BP1
SCHEMBL5790204 0.83 AGXT (0.61) PRMT6AGXTDRD3ADRA2C
SCHEMBL7508176 0.82 PRMT6 (0.47) PRMT6AGXTMBTD1TP53BP1L3MBTL3
SCHEMBL4577359 0.81 KHK (0.47) PRMT6AGXTMAPTSMN1; SMN2KDM4E
SCHEMBL8200502 0.81 AGXT (0.60) PRMT6AGXTADRA2C
SCHEMBL25497793 0.80 L3MBTL3 (0.45) PRMT6AGXTMBTD1TP53BP1L3MBTL3
SCHEMBL4577574 0.80 CHRNA7 (0.56) PRMT6AGXTMAPTSMN1; SMN2DRD2
SCHEMBL23844193 0.79 L3MBTL3 (0.44) PRMT6AGXTMBTD1TP53BP1L3MBTL3
SCHEMBL13005475 0.77 HRH3 (0.46) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419413-A1 DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES Takeda Pharmaceutical Company Limited (JP) 2012-02-22 EP disclosed
WO-2010119992-A1 DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-10-21 WO disclosed